1-20 of 22
Elmar Stickeler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO1-23-02: Magnetic seeds used for the detection of target lymph nodes after neoadjuvant therapy for early breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

Free
Hans-Christian Kolberg, Steffi Hartmann, Maggie Banys-Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Davide Gentilini, Sarah Fröhlich, Marc Thill, Michael P. Lux, Guldeniz Karadeniz Cakmak, Isabel Rubio, Michalis Kontos, Rosa Di Micco, Dawid Murawa, Thorsten Kühn
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO1-23-02.
https://doi.org/10.1158/1538-7445.SABCS23-PO1-23-02
Published: 02 May 2024
View articletitled, Abstract PO1-23-02: Magnetic seeds used for the detection of target lymph nodes after neoadjuvant therapy for early breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
Journal Articles

Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL

Free
Marc Thill, Mark-Oliver Zahn, Anja Welt, Arnd Nusch, Matthias Zaiss, Kathrin Engelken, Gabriele Kaltenecker, Kai Ringwald, Katja Gratzke, Lisa Kruggel, Martina Jänicke, Holger Schulz, Christoph Losem, Volker Hagen, Roland Fricker, Elmar Stickeler, Nadia Harbeck, Achim Wöckel, Thomas Decker
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO1-04-12.
https://doi.org/10.1158/1538-7445.SABCS23-PO1-04-12
Published: 02 May 2024
View articletitled, Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Journal Articles

Abstract PO3-23-03: Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

Free
Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, Oreste Davide Gentilini, Timo Basali, Elmar Stickeler, Michael Untch, Franziska Ruf, Sarah Fröhlich, Marc Thill, Michael P. Lux, Florentia Peintinger, Guldeniz Karadeniz Cakmak, Isabel Rubio, Michalis Kontos, Rosa Di Micco, Dawid Murawa, Ellen Schlichting, Bilge Aktas Sezen, Achim Rody, Dagmar Langanke, Nana Bündgen, Jose Ignacio Sanchez-Mendez, Renu Buss-Steidle, Christine Mau, Nana Buchmann, Sabine Riemer, Marit Helene Hansen, Nina Ditsch, Thorsten Kühn
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-23-03.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-23-03
Published: 02 May 2024
View articletitled, Abstract PO3-23-03: Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
Journal Articles

Abstract PO5-25-12: CDH1 mutations predict resistance to neoadjuvant taxane therapy

Free
Stian Knappskog, Reham Helwa, Sivaramakrishna Rachakonda, Liv B. Gansmo, Carsten Denkert, Lucy R. Yates, Christine Solbach, Michael Untch, Bruno V. Sinn, Anne-Sophie Litmeyer, Beyhan Ataseven, Jens Huober, David C. Wedge, Thomas Karn, Oleksii Nikolaienko, Frederik Marmé, Peter A. Fasching, Hans Petter Eikesdal, Elmar Stickeler, Christian Schem, Paul Jank, Marion van Mackelenbergh, Volkmar Müller, Baerbel Felder, Johannes Holtschmidt, Peter J. Campbell, Sibylle Loibl, Per Lonning
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO5-25-12.
https://doi.org/10.1158/1538-7445.SABCS23-PO5-25-12
Published: 02 May 2024
View articletitled, Abstract PO5-25-12: CDH1 mutations predict resistance to neoadjuvant taxane therapy
Journal Articles

Abstract PO4-19-04: AXSANA – EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Free
Thorsten Kühn, Steffi Hartmann, Elmar Stickeler, Jana de Boniface, Oreste Davide Gentilini, Sarah Fröhlich, Franziska Ruf, Marc Thill, Michael Hauptmann, Guldeniz Karadeniz Cakmak, Isabel Rubio, Maria Luisa Gasparri, Michalis Kontos, Eduard-Alexandru Bonci, Laura Niinikoski, Bilge Aktas Sezen, Rosa Di Micco, Dawid Murawa, Geeta Kadayaprath, David Pinto, Florentia Peintinger, Matilda Appelgren, Janine M. Simons, Marjolein Smidt, Ellen Schlichting, Lukas Dostalek, Elisabeth Thiemann, Markus Hahn, Michael Schrauder, Semra Gunay, Gunay Gurleyik, Nina Helidon, Hagigat Valiyeva, Ashutosh Kothari, Marian Vanhoeij, Andraz Perhavec, Tsvetomir Ivanov, Dov Zippel, Lia Rebaza, Sarun Thongvitokomarn, Sibylle Loibl, Maggie Banys-Paluchowski
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-19-04.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-19-04
Published: 02 May 2024
View articletitled, Abstract PO4-19-04: AXSANA – EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
Journal Articles

Abstract PD9-04: Immunological and clinical consequences of durvalumab treatment in combination to neoadjuvant chemotherapy in triple-negative breast cancer patients

Free
Chiara Massa, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens-Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marmé, Jens Huober, Volkmar Müller, Christian Schem, Anja Müller, Elmar Stickeler, Katharina Biehl, Peter A. Fasching, Michael Untch, Sibylle Loibl, Carsten Denkert, Barbara Seliger
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD9-04.
https://doi.org/10.1158/1538-7445.SABCS22-PD9-04
Published: 01 March 2023
View articletitled, Abstract PD9-04: Immunological and clinical consequences of durvalumab treatment in combination to neoadjuvant chemotherapy in triple-negative breast cancer patients
Journal Articles

Abstract P4-04-14: Immunological markers in patients with breast cancer occurring during pregnancy - Results from GBG BCP study

Free
Kristin Galas, Moritz Gleitsmann, Julia Rey, Christine Solbach, Isabell Witzel, Thomas Karn, Andreas Schneeweiss, Bruno Sinn, Tanja Fehm, Carsten Denkert, Volkmar Müller, Anne-Sophie Litmeyer, Christian Schem, Paul Jank, Frederik Marmé, Jenny Furlanetto, Peter A. Fasching, Elmar Stickeler, Olaf Ortmann, Marion van Mackelenbergh, Valentina Nekljudova, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P4-04-14.
https://doi.org/10.1158/1538-7445.SABCS21-P4-04-14
Published: 15 February 2022
View articletitled, Abstract P4-04-14: Immunological markers in patients with breast cancer occurring during pregnancy - Results from GBG BCP study
Journal Articles

Abstract OT1-02-01: Phase III postneoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment - SASCIA

Free
Frederik Marmé, Marcus Schmidt, Jenny Furlanetto, Carsten Denkert, Anthony Goncalves, Elmar Stickeler, Mattea Reinisch, Silvia Antolín, Toralf Reimer, Wolfgang Janni, Philippe Aftimos, Michael Untch, Laura Michel, Marija Balic, Bruno Sinn, Volker Möbus, Patrick Morris, Laura Schöllhorn, Sabine Schmatloch, Julia Rey, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-02-01.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-02-01
Published: 15 February 2022
View articletitled, Abstract OT1-02-01: Phase III postneoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment - SASCIA
Journal Articles

Abstract OT1-04-04: AXSANA - EUBREAST 3 (axillary surgery after neoadjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Free
Thorsten Kühn, Steffi Hartmann, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Sarah Fröhlich, Franziska Ruf, Marc Thill, Michael Hauptmann, Guldeniz Karadeniz Cakmak, Isabel Rubio, Maria Luisa Gasparri, Michaelis Kontos, Eduard-Alexandru Bonci, Laura Niinikoski, Rosa Di Micco, Dawid Murawa, David Pinto, Florentia Peintinger, Christine Solbach, Matilda Appelgren, Jens-Uwe Blohmer, Michael Weigel, Gabriele Kaltenecker, Michael Schrauder, Janine Simons, Marjolein Smidt, Ellen Schlichting, Lukas Dostalek, Alexander Sergeevich Emelyanov, Elisabeth Thiemann, Semra Gunay, Sybille Loibl, Maggie Banys-Paluchowski
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-04-04.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-04-04
Published: 15 February 2022
View articletitled, Abstract OT1-04-04: AXSANA - EUBREAST 3 (axillary surgery after neoadjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
Journal Articles

Abstract OT-04-02: The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Free
Maggie Banys-Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Marc Thill, Steffi Hartmann, Marina Mangold, Christine Solbach, Jens-Uwe Blohmer, Michael Untch, Matilda Appelgren, Hans-Christian Kolberg, Thorsten Kühn, EUBREAST
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-04-02.
https://doi.org/10.1158/1538-7445.SABCS20-OT-04-02
Published: 15 February 2021
View articletitled, Abstract OT-04-02: The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
Journal Articles

Abstract PS11-16: Rare patients in routine care: Treatment and outcome in advanced invasive lobular breast cancer in the prospective German research platform OPAL

Free
Marc Thill, Mark-Oliver Zahn, Anja Welt, Elmar Stickeler, Arnd Nusch, Thomas Fietz, Jacqueline Rauh, Natalie Wetzel, Lisa Kruggel, Martina Jänicke, Norbert Marschner, Nadia Harbeck, Achim Wöckel, Thomas Decker, OPAL study group
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS11-16.
https://doi.org/10.1158/1538-7445.SABCS20-PS11-16
Published: 15 February 2021
View articletitled, Abstract PS11-16: Rare patients in routine care: Treatment and outcome in advanced invasive lobular breast cancer in the prospective German research platform OPAL
Journal Articles

Abstract LB-018: Chemotherapeutic stress influences epithelial-mesenchymal transition and stemness in cancer stem cells of triple‐negative breast cancer

Free
Xiao Li, Juliane Strietz, Andreas Bleilevens, Elmar Stickeler, Jochen Maurer
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): LB-018.
https://doi.org/10.1158/1538-7445.AM2020-LB-018
Published: 15 August 2020
View articletitled, Abstract LB-018: Chemotherapeutic stress influences epithelial-mesenchymal transition and stemness in cancer stem cells of triple‐negative breast cancer
Journal Articles

Abstract P2-17-01: Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany

Free
Elmar Stickeler, Nadia Harbeck, Marc Thill, Arnd Nusch, Marco Chiabudini, Lisa Kruggel, Martina Jänicke, Norbert Marschner, Mark-Oliver Zahn, Anja Welt, Achim Wöckel, Thomas Decker, OPAL Study Group
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P2-17-01.
https://doi.org/10.1158/1538-7445.SABCS19-P2-17-01
Published: 15 February 2020
View articletitled, Abstract P2-17-01: Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany
Journal Articles

Abstract P4-04-08: Histological and epigenetic analyses of placenta tissue from breast cancer patients and healthy participants

Free
Karolin Fröhlich, Torsten Plösch, Fenja Seither, Volkmar Müller, Thomas Karn, Elmar Stickeler, Christian Schem, Christine Solbach, Amelie Lupp, Rikst N Verkaik-Schakel, Gitta Turowski, Peter Mallmann, Marion van Mackelenbergh, Bruno Sinn, Valentina Nekljudova, Carsten Denkert, Pamela Schittler, Udo Markert, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-04-08.
https://doi.org/10.1158/1538-7445.SABCS19-P4-04-08
Published: 15 February 2020
View articletitled, Abstract P4-04-08: Histological and epigenetic analyses of placenta tissue from breast cancer patients and healthy participants
Journal Articles

Abstract P1-10-01: Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer

Free
Terence Williams, Andreas Schneeweiss, Christian Jackisch, Changxian Shen, Karsten Weber, Peter Fasching, Carsten Denkert, Jenny Furlanetto, Ernst Heinmoller, Sabine Schmatloch, Thomas Karn, Christopher Szeto, Marion van Mackelenbergh, Valentina Nekljudova, Elmar Stickeler, Patrick Soon-Shiong, Christian Schem, Barbara Fleige, Volkmar Muller, Frederik Marme, Michael Untch, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-10-01.
https://doi.org/10.1158/1538-7445.SABCS19-P1-10-01
Published: 15 February 2020
View articletitled, Abstract P1-10-01: Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer
Journal Articles

Abstract P6-10-04: Landscape of immune-cell signatures in early high-risk breast cancer (BC) reveals clinically-relevant enrichment of immune subpopulations

Free
Christopher Szeto, Carsten Denkert, Peter A Fasching, Stephen Benz, Karsten E Weber, Jan Budczies, Andreas Schneeweiss, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans P Sinn, Mathias Warm, Marion van Mackelenbergh, Shahrooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Müller, Frederik Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Sibylle Loibl, Michael Untch
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-10-04.
https://doi.org/10.1158/1538-7445.SABCS19-P6-10-04
Published: 15 February 2020
View articletitled, Abstract P6-10-04: Landscape of immune-cell signatures in early high-risk breast cancer (BC) reveals clinically-relevant enrichment of immune subpopulations
Journal Articles

Abstract PD5-08: Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial

Free
Peter A Fasching, Carsten Denkert, Stephen Benz, Karsten E Weber, Christopher Szeto, Jan Budczies, Andreas Schneeweiss, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans Peter Sinn, Mathias Warm, Marion van Mackelenbergh, Sharooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Müller, Frederik Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Michael Untch, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD5-08.
https://doi.org/10.1158/1538-7445.SABCS19-PD5-08
Published: 15 February 2020
View articletitled, Abstract PD5-08: Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial
Journal Articles

KDM4 Inhibition Targets Breast Cancer Stem–like Cells

Free
Eric Metzger, Stella S. Stepputtis, Juliane Strietz, Bogdan-Tiberius Preca, Sylvia Urban, Dominica Willmann, Anita Allen, Fides Zenk, Nicola Iovino, Peter Bronsert, Amelie Proske, Marie Follo, Melanie Boerries, Elmar Stickeler, Jiangchun Xu, Michael B. Wallace, Jeffrey A. Stafford, Toufike Kanouni, Jochen Maurer, Roland Schüle
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (21): 5900–5912.
https://doi.org/10.1158/0008-5472.CAN-17-1754
Published: 31 October 2017
View articletitled, KDM4 Inhibition Targets Breast Cancer Stem–like Cells
Open the PDF for KDM4 Inhibition Targets Breast Cancer Stem–like Cells in another window
Includes: Supplementary data
Journal Articles

Abstract S3-04: The phase III ICE study: Adjuvant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer

Free
Gunter von Minckwitz, Toralf Reimer, Jochen Potenberg, Bettina Conrad, Ulrike Schürer, Holger Eidtmann, Marianne Just, Stefan Paepke, Elmar Stickeler, Georg Heinrich, Michael Untch, Volker Moebus, Christoph Thomssen, Christian Jackisch, Jens Huober, Sibylle Loibl, Valentina Nekljudova, Ulrike Nitz
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): S3-04.
https://doi.org/10.1158/1538-7445.SABCS14-S3-04
Published: 01 May 2015
View articletitled, Abstract S3-04: The phase III ICE study: Adjuvant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer
Journal Articles

Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer

Free
Marc Hirschfeld, Axel zur Hausen, Herta Bettendorf, Markus Jäger, Elmar Stickeler
Journal: Cancer Research
Cancer Res (2009) 69 (5): 2082–2090.
https://doi.org/10.1158/0008-5472.CAN-08-1997
Published: 02 March 2009
View articletitled, Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer
Open the PDF for Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer in another window